20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11776 | KRas G12C inhibitor 1 | Ras | |
KRas G12C inhibitor 1 is a compound that inhibits KRas G12C. | |||
T77805 | KRAS G12C mutant protein inhibitor A-1 | ||
T11224 | Rineterkib | ERK-IN-1 | ERK , Raf |
Rineterkib (ERK-IN-1) is an inhibitor of RAF and ERK1/2 activating mutations in the MAPK pathway. | |||
T62566 | KRAS G12C inhibitor 53 | ||
KRAS G12C inhibitor 53 (Compound 1) is a KRAS G12C inhibitor. | |||
T11768 | KRAS G12C inhibitor 14 | Ras | |
KRAS G12C inhibitor 14 is a potent KRAS G12C inhibitor with an IC 50 of 18 nM [1]. | |||
T79057 | KRAS G12C inhibitor 58 | Ras | |
KRAS G12C inhibitor 58 is utilized in cancer research as an inhibitor of the KRAS G12C mutation [1]. | |||
T72335 | KRAS G12C inhibitor 32 | Ras | |
KRAS G12C Inhibitor 32, an eight-membered heterocyclic compound with nitrogen, acts as a potent inhibitor of KRAS G12C [1]. | |||
T72336 | KRAS G12C inhibitor 45 | ||
KRAS G12C inhibitor 45 is a potent KRAS G12C inhibitor . | |||
T79166 | KRAS G12C inhibitor 60 | Ras | |
KRAS G12C Inhibitor 60 (compound 23), a selective inhibitor targeting the Kras-G12C mutation, is utilized in the investigation of lung, colorectal, and pancreatic cancers [1]. | |||
T64085 | KRAS G12C inhibitor 43 | ||
KRAS G12C inhibitor 43 is a potent inhibitor of KRAS G12C and inhibits the migration and proliferation of H358 cells (IC50: 0.001-1 μM μM), A549 cells (IC50>1 μM) and HCC cells (IC50>1 μM). | |||
T78651 | Glecirasib | JAB-21822,KRAS G12C inhibitor 36 | Ras |
Glecirasib (KRAS G12C inhibitor 36) is a potent inhibitor targeting the oncogenic KRAS G12C mutation, a key signaling molecule within the Ras protein family that is crucial for cell growth and development. This compound ... | |||
T79799 | Pan-KRAS-IN-4 | Ras | |
Pan-KRAS-IN-4 (compound 5) is a potent KRAS inhibitor, demonstrating IC50 values of 0.37 nM for Kras G12C and 0.19 nM for Kras G12V [1]. | |||
T73396 | ARS-2102 | ||
ARS-2102 is a potent covalent KRAS G12C inhibitor for use in cancer research . | |||
T62751 | KRAS inhibitor-12 | ||
KRAS inhibitor-12 (compound 6-1) is a potent inhibitor of KRAS G12C (IC50: 0.537 μM). KRAS inhibitor-12 exhibits p-ERK inhibition in MIA PaCA-2, A549 cells with IC50 values of 1.3, 3.7 μM respectively. KRAS inhibitor-12 ... | |||
T79092 | TH-Z827 | Ras | |
TH-Z827 is a mutant-selective inhibitor targeting KRAS(G12D) with an IC50 of 2.4 μM, demonstrating specificity by not binding to KRAS(WT) or KRAS(G12C). Additionally, it disrupts the KRAS(G12D)-CRAF interaction with an I... | |||
T75131 | RMC-6291 | ||
RMC-6291 is an orally active and covalent inhibitor of KRAS G12C (ON) . RMC-6291 forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA). Thus, RMC-6291 prevents KRAS G12C (ON) from signali... | |||
T72971 | (S)-JDQ-443 | (S)-NVP-JDQ443 | |
(S)-JDQ-443 is an isomer of JDQ-443 . JDQ-443 is an orally active, potent, selective, and covalent KRAS G12C inhibitor. JDQ-443 shows antitumor activity [1] [2] . | |||
T79808 | KRAS G12C inhibitor 61 | ERK | |
KRAS G12C inhibitor 61 (Example 3) demonstrates potent activity by inhibiting phospho-ERK 1/2 in MIA PaCa-2 cells, reflected in an IC50 value of 9 nM. This inhibitor is applicable in the research of pancreatic, colorecta... | |||
T79800 | Pan-KRAS-IN-2 | Ras | |
Pan-KRAS-IN-2 (compound 6) is a broad-spectrum KRAS inhibitor exhibiting potent activity with IC50 values of ≤10 nM against KRAS wild type and its mutants (G12D, G12C, G12V, G12S, G12A, Q61H), while showing significantly... | |||
T75119 | KRASG12C IN-2 | ||
KRASG12C IN-2 (compound 17) is an orally active inhibitor of KRAS G12C, which effectively suppresses tumor growth in mice [1]. |